Additionally, compared to the ACA-positive group, patients with SSA-positive pSS exhibited a significantly higher rate of hematological involvement, encompassing anemia, leukopenia, and neutropenia, than those in the ACA-positive group (P < 0.05). This evidence concerns the gene CALR and Decreased total neutrophil count.